Preliminary list of companies to be profiled in drug-eluting stent market report, listed below. I know what you’re thinking — you had no idea there were so many.
- Abbott Vascular
- AdvanSource Biomaterials
- Aeon Bioscience
- Arterial Remodeling Technologies (ART)
- Atrium Medical
- Avantec Vascular
- B. Braun Melsungen
- Bioabsorbable Therapeutics, Inc. (BTI)
- Biocompatibles International plc
- Biosensors International PTE Ltd.
- Biosync Scientific Pvt. Ltd.
- Biotronik
- Blue Medical Devices B.V.
- Boston Scientific
- Capella Inc.
- CardioMind, Inc.
- CeloNova BioSciences
- CID (Carbostent & Implantable Devices) SRL
- Cinvention AG (Formerly Blue Membranes)
- Conor Medsystems (J&J)
- Cordis (J&J)
- CorNova
- CV Therapeutics
- Devax
- DISA Vascular
- Elixir Medical Corporation
- Endovasc
- Estracure
- EuroCor
- Global Therapeutics (Cook Medical)
- Hexacath
- ICON Interventional
- InspireMD
- Invatec S.p.A.
- JW Medical Systems/Biosensors International
- Kaneka Corporation
- Kyoto Medical Planning Co., Ltd.
- Lepu Medical
- Medinol/ARIAD Pharmaceuticals
- Medlogics Device Corporation (MDC)
- Medtronic Vascular
- Miami Cardiovascular Innovations (MCVI)
- Micell Technologies
- MicroPort Scientific Corporation
- Minvasys
- MIV Therapeutics
- NanoInterventions, LLC
- Neovasc Inc.
- Nexeon MedSystems, Inc.
- Opto Circuits Ltd.
- OrbusNeich
- Picarus NV
- Prescient Medical
- Relisys Medical Devices
- REVA Medical
- Sahajanand Medical Technologies
- Stentys
- Terumo
- Translumina
- TriReme Medical
- Tryton Medical
- Vascore Medical
- Vascular Concepts
- X-Cell Medical
- Xtent
This report is publishing in March. 2009
bookmark to
Drug-eluting, bare metal and bioresobable coronary stent companies
